Добро пожаловать
Нажатие «Авторизоваться» означает, что вы соглашаетесь с Условия использования и политика конфиденциальности Cointime.
Зарегистрировать аккаунт
Аккаунт уже существует?
Нажатие «page.Sign up» означает, что вы соглашаетесь с <a class="underline" href="#term-of-service">Условия использования</a> и a class="underline" href="#privacy-policy">политика конфиденциальности</a> Cointime.
Войдите, используя email
Зарегистрируйтесь с помощью email
твой почтовый ящик
Проверь свои входящие
Нажмите на ссылку в , чтобы войти.
Нажмите на ссылку в , чтобы зарегистрироваться.
Microbion
company
About
Microbion is a pharmaceutical company developing therapeutics for the treatment of bacterial infections.
- 11 - 50
Highlights
Details
- Last Funding Type
- Series Unknown
- Last Funding Money Raised
- $25M
- Industries
- Biotechnology,Health Care,Pharmaceutical,Therapeutics
- Founded date
- Jan 1, 1982
- Number Of Employee
- 11 - 50
- Operating Status
- Active
Microbion is a pharmaceutical company that focuses on the development of therapeutics for the treatment of bacterial infections. It develops bismuth-thiols to prevent microbial biofilms from forming on medical devices implanted in the body and to prevent microbial biofilms in agricultural crops and industrial surfaces, including ships’ hulls, pulp and paper, and oil industries. It was founded in 1982 and headquartered in Bozeman, Montana.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
1
$25M
Microbion has raised a total of
$25M
in funding over 2 rounds. Their latest funding was raised on
Jan 5, 2017 from a Series Unknown round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Jan 5, 2017 | Series Unknown | $25M | 1 |
|
— | Detail |
Investors
Number of Lead Investors
Number of Investors
1
1
Microbion is funded by 1 investors.
Global health sciences venture fund
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
|
Yes | Series Unknown |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
